Tricyclic compounds
US8962629B2 · kind B2 · utility
54Cited by
23References
53Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 9, 2009 |
| Grant date | Feb 24, 2015 |
| Priority date | — |
| Expiry date | Dec 16, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a compound of Formula (I)pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.